Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology Article

Agoulnik, Irina U, Kaftanovskaya, Elena M, Myhr, Courtney et al. (2024). Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology . BIOCHEMICAL PHARMACOLOGY, 227 10.1016/j.bcp.2024.116401

International Collaboration

cited authors

  • Agoulnik, Irina U; Kaftanovskaya, Elena M; Myhr, Courtney; Bathgate, Ross AD; Kocan, Martina; Peng, Yingjie; Lindsay, Ronald M; Distefano, Peter S; Agoulnik, Alexander I

sustainable development goals

publication date

  • September 1, 2024

published in

keywords

  • ACUTE HEART-FAILURE
  • BINDING
  • CELLS
  • FIBROSIS
  • Fibrosis
  • H3
  • Life Sciences & Biomedicine
  • Pharmacology & Pharmacy
  • Protein-in-Protein
  • RECEPTOR
  • RECOMBINANT HUMAN RELAXIN-2
  • RXFP1
  • Relaxin
  • SERELAXIN
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • PERGAMON-ELSEVIER SCIENCE LTD

volume

  • 227